Literature DB >> 22722462

Pseudoxanthoma elasticum-like papillary dermal elastolysis: immunohistochemical study using elastic fiber cross-reactivity with an antibody against amyloid P component.

Juan M Revelles1, Salma Machan, Ursula Pielasinski, Diana Camacho, Lara Vallés, Carlos Santonja, Heinz Kutzner, Luis Requena.   

Abstract

Pseudoxanthoma elasticum (PXE)-like papillary dermal elastolysis is a rare disorder clinically characterized by multiple, asymptomatic nonfollicular papules, yellow or flesh colored, grouped to form plaques with cobblestone appearance. These plaques are arranged symmetrically on the neck and supraclavicular areas of adult or elderly women, closely resembling the lesions of PXE. Histopathologically, the lesions are characterized by a band-like area of elastolysis along the papillary dermis. We report 2 cases of PXE-like papillary dermal elastolysis, in which the anomalies of the elastic tissue were immunohistochemically investigated with an antibody to the amyloid P component. This immunostaining demonstrated a band-like loss of elastic tissue along the papillary dermis. No clumping, fragmentation, or calcification of the elastic tissue was seen. We also review the literature about this rare process and discuss the differential diagnosis with other elastic tissue disorders that may show similar clinical and/or histopathologic findings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722462     DOI: 10.1097/DAD.0b013e318257be63

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Pseudoxanthoma elasticum-like papillary dermal elastolysis in non-exposed skin.

Authors:  Nuria Setó-Torrent; Maribel Iglesias-Sancho; Jorge Arandes-Marcocci; María Teresa Fernández-Figueras
Journal:  An Bras Dermatol       Date:  2020-02-12       Impact factor: 1.896

2.  Dermoscopy of a Case of Pseudoxanthoma Elasticum: A Step Closer to Diagnosis.

Authors:  Payal Chauhan; Sheenam Sethi; Rashmi Jindal
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.